Stay updated with breaking news from Authorization Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia announces financial results for 2021 – 2022 to be a transformative year – Sustainable profitability expected in 2025
08.02.2022 - Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – February 8, 2022 Idorsia Ltd (SIX: IDIA) today announced its financial results for 2021. Business highlights QUVIVIQ (daridorexant) 25 mg and 50 mg approved by the US Food and ...
Real-world experience study of more than 3,100 patients demonstrates statistically significant reductions in transfusions, vaso-occlusive crises and hospitalizations in patients treated with... | December 12, 2021
Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for Advanced Liver Fibrosis Due to NASH New York, -- Intercept Pharmaceuticals,... | December 9, 2021
/PRNewswire/ -- Hansa on track to achieve key 2021 objectives: Agreements on funding obtained in three countries; HTA submissions in ten countries; and...